Related references
Note: Only part of the references are listed.Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis
Mitzy Kennis et al.
MOLECULAR PSYCHIATRY (2020)
An electroencephalographic signature predicts antidepressant response in major depression
Wei Wu et al.
NATURE BIOTECHNOLOGY (2020)
Electroencephalographic Biomarkers for Predicting Antidepressant Response New Methods, Old Questions
Adrienne Grzenda et al.
JAMA PSYCHIATRY (2020)
Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder Secondary Analysis of a Randomized Clinical Trial
Camarin E. Rolle et al.
JAMA PSYCHIATRY (2020)
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Kristin Kohler-Forsberg et al.
FRONTIERS IN PSYCHIATRY (2020)
Depression and Sleep
Axel Steiger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis
Alik S. Widge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression A Randomized Clinical Trial
Diego A. Pizzagalli et al.
JAMA PSYCHIATRY (2018)
Brain arousal regulation as response predictor for antidepressant therapy in major depression
Frank M. Schmidt et al.
SCIENTIFIC REPORTS (2017)
Future of clinical EEG in psychiatric disorders: Shifting the focus from diagnosis to the choice of optimal treatment
Sebastian Olbrich et al.
CLINICAL NEUROPHYSIOLOGY (2016)
EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study
Martijn Arns et al.
CLINICAL NEUROPHYSIOLOGY (2016)
Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton melancholia subscale (HAM-D6) as outcome measure
Soren Dinesen Ostergaard et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study
Sebastian Olbrich et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Objective markers for sleep propensity: comparison between the Multiple Sleep Latency Test and the Vigilance Algorithm Leipzig
Sebastian Olbrich et al.
JOURNAL OF SLEEP RESEARCH (2015)
Brain Arousal Regulation in Carriers of Bipolar Disorder Risk Alleles
Philippe Jawinski et al.
NEUROPSYCHOBIOLOGY (2015)
The vigilance regulation model of affective disorders and ADHD
Ulrich Hegerl et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Separation of Low-Voltage EEG-Activity During Mental Activation from that During Transition to Drowsiness
Johannes Joedicke et al.
BRAIN TOPOGRAPHY (2013)
EEG biomarkers in major depressive disorder: Discriminative power and prediction of treatment response
Sebastian Olbrich et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
EEG Vigilance Regulation Patterns and Their Discriminative Power to Separate Patients with Major Depression from Healthy Controls
Sebastian Olbrich et al.
NEUROPSYCHOBIOLOGY (2012)
Hyperstable regulation of vigilance in patients with major depressive disorder
Ulrich Hegerl et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Impact of EEG-vigilance on brain glucose uptake measured with [18F]FDG and PET in patients with depressive episode or mild cognitive impairment
Thomas Guenther et al.
NEUROIMAGE (2011)
HAM-D17 and HAM-D6 Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder
P. Beth et al.
PHARMACOPSYCHIATRY (2010)
EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement
Sebastian Olbrich et al.
NEUROIMAGE (2009)
Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers:: evidence for desensitization of the 5-HT1A autoreceptor
R. Hamish McAllister-Williams et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder
Per Bech et al.
PSYCHOPHARMACOLOGY (2006)
EEG effects of buspirone and pindolol:: a method of examining 5-HTIA receptor function in humans
RH McAllister-Williams et al.
PSYCHOPHARMACOLOGY (2003)
Contribution of sleep physiology to depressive pathophysiology
E Seifritz
NEUROPSYCHOPHARMACOLOGY (2001)
Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man:: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA)
P Anderer et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2000)
Share Paper
